Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Localized Prostate Adenocarcinoma”

155 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 155 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03367702
What this trial is testing

Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer

Who this might be right for
Stage II Prostate Adenocarcinoma AJCC v7
NRG Oncology 692
Testing effectiveness (Phase 2)Study completedNCT00589472
What this trial is testing

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00345813
What this trial is testing

Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Wake Forest University Health Sciences 62
Testing effectiveness (Phase 2)Looking for participantsNCT07332000
What this trial is testing

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Who this might be right for
Prostate Cancer Patients Treated by RadiotherapyProstate Cancer (Adenocarcinoma)
Candel Therapeutics, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT03384199
What this trial is testing

Dose Escalation Using Fiducial Markers in Image Guided Volumetric Modulated Arc Therapy to the Focal Lesion Micro Boost of Localized Prostate Cancer

Who this might be right for
Prostatic Adenocarcinoma
Kasr El Aini Hospital 30
Not applicableLooking for participantsNCT07042256
What this trial is testing

Feasibility of MR-Informed Adaptive Marker-less SBRT in Patients With Bilateral Hip Prostheses Undergoing SBRT for Localized Prostate Cancer

Who this might be right for
Localized Prostate Adenocarcinoma
University of Zurich 13
Testing effectiveness (Phase 2)Study completedNCT00225420
What this trial is testing

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Active Not RecruitingNCT04295447
What this trial is testing

Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy

Who this might be right for
Prostatic Neoplasms
Universität Münster 190
Not applicableLooking for participantsNCT07407608
What this trial is testing

ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0

Who this might be right for
Prostate CancerProstate Cancer (Adenocarcinoma)Prostate Cancer Non-Metastatic
University of Milano Bicocca 58
Not applicableUnknownNCT03284151
What this trial is testing

Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma

Who this might be right for
Prostate Cancer
Centre Francois Baclesse, Luxembourg 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT04045717
What this trial is testing

Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0

Who this might be right for
Prostate AdenocarcinomaProstate CancerProstate Neoplasm
Universitaire Ziekenhuizen KU Leuven 124
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)WithdrawnNCT04020094
What this trial is testing

Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
University of Utah
Not applicableUnknownNCT05599737
What this trial is testing

Stereotactic Prostate Radiotherapy With Dose Escalation Focused on the "Dominant Intra-prostatic Lesion" (DIPL) Delineated by Multi-parametric MRI and 68Ga-PSMA PET (Prostate-SIB-PSMA)

Who this might be right for
Prostate Adenocarcinoma
Centre Leon Berard 30
Testing effectiveness (Phase 2)Study completedNCT00080808
What this trial is testing

Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 111
Testing effectiveness (Phase 2)Active Not RecruitingNCT03541850
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery

Who this might be right for
PSA Level Greater Than 0.03PSA ProgressionStage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7+2 more
Jonsson Comprehensive Cancer Center 92
Testing effectiveness (Phase 2)UnknownNCT00045123
What this trial is testing

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

Who this might be right for
Prostate Cancer
Myrexis Inc.
Not applicableStudy completedNCT02254746
What this trial is testing

A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Centre Hospitalier Universitaire Vaudois 27
Testing effectiveness (Phase 2)WithdrawnNCT00811031
What this trial is testing

Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT04391556
What this trial is testing

Interest of PET-PSMA Imaging Potentialised by Androgen Blockade in Localized Prostatic Adenocarcinoma

Who this might be right for
Prostate Adenocarcinoma
Centre Leon Berard 57
Next Page